3Shape Inc
$19.3K 106 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Lombart Brothers, Inc.
Lombart Brothers, Inc. reported $19,314.39 across General Payments, Research, and Ownership to 220 physicians and teaching hospitals across 220 transactions.
- $19.3K Below-median payer
- All-tracks total
- 220 Above-median volume
- Transactions
- 220 Above-median reach
- Recipients
- +$2.8K
- General Payments vs PY2023
Lombart Brothers, Inc. reported $19,314.39 across all CMS Open Payments tracks (General + Research + Ownership) to 220 physicians and teaching hospitals in Program Year 2024 - ranking #1540 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $19,314.39, averaging $87.79 per recipient.
How Lombart Brothers, Inc.'s $19.3K all-tracks total breaks down
Lombart Brothers, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
10/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lombart-brothers-inc Lombart Brothers, Inc.
$19.3K · #1540/1,925 · 0.0% industry · PY2024
- TOT $19.3K
- RANK #1540
- SHARE 0.0%
- TXN 220
- RCP 220
- CAT 2
- GEN $19.3K
- ΔGEN +$2.8K
- TOP1 26.7%
- PY 2024
Volume peers
Nearest volume peer: 3Shape Inc ($19.3K)
Lombart Brothers, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Lombart Brothers, Inc.'s CMS-reported General Payments increased by $2.8K (+16.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LOMBART BROTHERS, INC.PY2023: LOMBART BROTHERS, INC.PY2024: Lombart Brothers, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $16,556.83
- PY2024
- $19,314.39
What the Data Shows for Lombart Brothers, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Lombart Brothers, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $14.1K, accounting for 73.1% of this company's General Payments and 217 transactions.
General Payment Breakdown by Type
Across 2 types of general payments, Lombart Brothers, Inc.'s largest category was "Food and Beverage" at $14.1K - 73.1% of General Payments.
How Lombart Brothers, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $14.1K | 217 | 73.1% |
| Entertainment | $5.2K | 3 | 26.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $9,079.23 (47.0%) of $19,314.39 in this company's General Payments records across 215 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lombart Brothers, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Shane Foster
$5,160.00 across 1 reported transactions
- 2
Nyssa D'Hedouville
$1,000.00 across 1 reported transactions
- 3
Jason Barnes
$1,000.00 across 1 reported transactions
- 4
Ryne Wood
$1,000.00 across 1 reported transactions
- 5
Glen Lojka
$919.23 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lombart Brothers, Inc. ranks #1540 of 1,925 by total payments (bottom 20% by spend) but is notably more concentrated than that alone would suggest -- #1,096 of 1,838 by HHI (bottom 40% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Radiometer America, Inc : $64.3K total payments, HHI 850
- Teladoc Health, Inc. : $9.9K total payments, HHI 847
- Delcath Systems : $329.6K total payments, HHI 847
- Roche Products Limited : $206.2K total payments, HHI 845
- Corcym Inc : $154.4K total payments, HHI 845
- Elutia, Inc. : $90.7K total payments, HHI 843
- Lombart Brothers, Inc. (this company) : $19.3K total payments, HHI 842
- iRhythm Technologies, Inc. : $1.5M total payments, HHI 840
- LinkBio Corp : $726.2K total payments, HHI 838
- Laborie Medical Technologies Corp. : $1.3M total payments, HHI 837
- Aurora Spine, Inc. : $1.4M total payments, HHI 836
- Cardiva Medical, Inc. : $715.0K total payments, HHI 833
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lombart Brothers, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lombart Brothers, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lombart Brothers, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Aero US Inc
$19.3K 27 recipients
Compare payment profiles
Akcea Therapeutics, Inc.
$19.2K 0 recipients
Compare payment profiles
Novabone Products
$19.0K 6 recipients
Compare payment profiles
Alvogen Inc
$19.0K 931 recipients
Compare payment profiles
Virtus Pharmaceuticals LLC
$19.8K 987 recipients
Compare payment profiles
Put this to use
Lombart Brothers, Inc. ranks #1540 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Lombart Brothers, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.